RADM Richard Childs is the Scientific Director of the National Heart, Lung, and Blood Institute (NHLBI) at NIH, where he leads one of its premier intramural research programs. Dr. Childs focuses on transplantation immunotherapy and was the first to demonstrate that donor immune cells could cure metastatic kidney cancer. He leads a translational research program in bone marrow transplantation and tumor immunotherapy, has performed more than 600 experimental transplants, and holds over 30 patents related to immune-based therapies. He also previously directed one of NIH’s largest clinical research programs, overseeing more than 250 clinical trials in heart, lung, and blood diseases.
Dr. Childs has also served as an active-duty officer in the U.S. Public Health Service Commissioned Corps since 1995, supporting major national and international public health responses.